Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors

Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors

US Patent 6969721 · Granted Nov 29, 2005

Estimated economic value: $42,895,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic urea compounds as JAK2 V617F inhibitors2025
Pyridine and pyridimine compounds as PI3K-gamma inhibitors2024
Tricyclic urea compounds as JAK2 V617F inhibitors2023
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2023
Tricyclic heterocycles as BET protein inhibitors2022
Pyridine and pyridimine compounds as PI3K-gamma inhibitors2022
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2022
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-12022
Tricyclic heterocycles as BET protein inhibitors2021
Tricyclic heterocycles as BET protein inhibitors2021
Process for preparing a composition comprising an enantiomeric excess of greater2021
Process for preparing a composition comprising an enantiomeric excess of greater2021